MGO One Seven’s Plus Therapeutics PSTV Stock Holding History

MGO One Seven’s Portfolio PSTV Stock Details PSTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1	Closed	-$2K	–	458
2019 Q2	$2K	Hold	1	–	–	﹤0.01%	406
2019 Q1	$2K	Hold	1	–	–	﹤0.01%	419
2018 Q4	$3K	Hold	1	–	–	﹤0.01%	1502
2018 Q3	$4K	Buy	+1	New	+$12.7K	﹤0.01%	356

Other funds holding PSTV

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quantamental Technologies White Plains, New York $106M AUM 22.9% 1-Year Est. Return

MGO One Seven's PSTV Position: Q3 2019 in Review

MGO One Seven sold out of Plus Therapeutics (PSTV) in Q3 2019, closing a stake of 1 share — an estimated $2K sold.

MGO One Seven first reported a position in PSTV in Q3 2018 and held it in 4 quarters. The position peaked at $4K in Q3 2018. 11 funds tracked by Wall St. Rank hold PSTV as of Q3 2019.

MGO One Seven reported no remaining Plus Therapeutics position as of Q3 2019 after selling out during the quarter.
MGO One Seven sold 1 Plus Therapeutics share in Q3 2019, an estimated $2K.
MGO One Seven first reported a position in Plus Therapeutics in Q3 2018 and held it in 4 quarters.
MGO One Seven's Plus Therapeutics position peaked at $4K in Q3 2018.
11 funds tracked by Wall St. Rank held Plus Therapeutics as of Q3 2019.

Based on MGO One Seven's 13F filing for Q3 2019, filed 10 Oct 2019.